Advisors Preferred, LLC Dr Reddys Laboratories LTD Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$67.36 - $77.59 $42,504 - $48,959	-631 Reduced 17.32%	3,013 $221,000
Q4 2023 Jan 24, 2024	BUY	$64.27 - $69.9 $234,199 - $254,715	3,644 New	3,644 $253,000
Q3 2019 Nov 12, 2019	SELL	$34.82 - $39.26 $49,618 - $55,945	-1,425 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$36.05 - $42.76 $51,371 - $60,933	1,425 New	1,425 $55,000

250

23.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.47B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.